Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Macrophages and T cells in metabolic disorder-associated cancers
Cancer and metabolic disorders have emerged as major global health challenges, reaching
epidemic levels in recent decades. Often viewed as separate issues, metabolic disorders …
epidemic levels in recent decades. Often viewed as separate issues, metabolic disorders …
Regulation of CD8+ T cells by lipid metabolism in cancer progression
Dysregulation of lipid metabolism is a key characteristic of the tumor microenvironment,
where tumor cells utilize lipids for proliferation, survival, metastasis, and evasion of immune …
where tumor cells utilize lipids for proliferation, survival, metastasis, and evasion of immune …
[HTML][HTML] Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases
Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are
chronic disorders characterized by dysregulated immune response and persistent …
chronic disorders characterized by dysregulated immune response and persistent …
[HTML][HTML] GLP-1R agonist therapy and vaccine response: Neglected implications
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide (Ozempic®),
have emerged as effective treatments for diabetes and weight management. However …
have emerged as effective treatments for diabetes and weight management. However …
[HTML][HTML] Safety and Efficacy of Sodium-Glucose Transport Protein 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Diabetic Kidney Transplant …
Background: This systematic review and meta-analysis aimed to evaluate the efficacy and
safety of novel antidiabetics, namely, sodium-glucose transport protein 2 inhibitors (SGLT2-i) …
safety of novel antidiabetics, namely, sodium-glucose transport protein 2 inhibitors (SGLT2-i) …
Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes
Non-alcoholic fatty liver disease (NAFLD), characterized by the excessive accumulation of
fat within the cytoplasm of hepatocytes (exceeding 5% of liver weight) in individuals without …
fat within the cytoplasm of hepatocytes (exceeding 5% of liver weight) in individuals without …
[HTML][HTML] Mechanism and therapeutic targets of circulating immune cells in diabetic retinopathy
B Zhao, Y Zhao, X Sun - Pharmacological Research, 2024 - Elsevier
Diabetic retinopathy (DR) continues to be the leading cause of preventable vision loss
among working-aged adults, marked by immune dysregulation within the retinal …
among working-aged adults, marked by immune dysregulation within the retinal …
Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonists
Clinically effective pharmacological treatment (s) for metabolic dysfunction-associated
steatotic liver disease (MASLD) and its progressive form metabolic dysfunction-associated …
steatotic liver disease (MASLD) and its progressive form metabolic dysfunction-associated …
Comparative outcomes of systemic diseases in people with type 2 diabetes, or obesity alone treated with and without GLP-1 receptor agonists: a retrospective cohort …
Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly used to
manage type 2 diabetes (T2D) and obesity. Despite their recognized benefits in glycemic …
manage type 2 diabetes (T2D) and obesity. Despite their recognized benefits in glycemic …
The growing range of complications of diabetes mellitus
With the rising prevalence of type 2 diabetes mellitus (T2DM) and obesity, several previously
under-recognised complications associated with T2DM are becoming more evident. The …
under-recognised complications associated with T2DM are becoming more evident. The …